MapLight Therapeutics, Inc. (MPLT) reporting calendar
MapLight Therapeutics, Inc. files periodic reports with the SEC as MPLT on Nasdaq. Atlas tracks 3 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 14 May 2026
- Reports on record
- 3
Open MPLT market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 14 May 2026 | 44 days | 0001193125-26-224129 |
| 10-K | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001193125-26-125072 |
| 10-Q | 30 Sep 2025 | 4 Dec 2025 | 65 days | 0001193125-25-307453 |
Source: SEC EDGAR company submissions for CIK 0001770069. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.